CBLN1 and breast cancer: Differing from the BC group, the BL group (Figure 3d and Figure S5d) presented increased levels of 3 metabolites (including 1-DNJ and oxytetracycline), whereas 45 metabolites (specifically fumonisin B2, uric acid, and Cer (8:1_20/24:4)) were downregulated.